Pasha, Dalal N.; Davis, Jason T.; Rao, Fangwen; Chen, Yuqing; Wen, Gen; Fung, Maple M.; Mahata, Manjula; Zhang, Kuixing; Trzebinska, Danuta; Mustapić, Maja; Hightower, C. Makena; Lipkowitz, Michael S.; Ji, Ming; Ziegler, Michael G.; Nievergelt, Caroline M.; O'Connor, Daniel T. (2013) Heritable Influence of DBH on Adrenergic and Renal Function: Twin and Disease Studies. PLoS One, 8 (12). ISSN 1932-6203
|
PDF
- Published Version
- article
Available under License Creative Commons Attribution. Download (805kB) | Preview |
Abstract
Abstract Background: Elevated sympathetic activity is associated with kidney dysfunction. Here we used twin pairs to probe heritability of GFR and its genetic covariance with other traits. Methods: We evaluated renal and adrenergic phenotypes in twins. GFR was estimated by CKD-EPI algorithm. Heritability and genetic covariance of eGFR and associated risk traits were estimated by variance- components. Meta-analysis probed reproducibility of DBH genetic effects. Effect of DBH genetic variation on renal disease was tested in the NIDDK-AASK cohort. Results: Norepinephrine secretion rose across eGFR tertiles while eGFR fell (p, 0.0001). eGFR was heritable, at h2= 67.364.7% (p = 3.0E-18), as were secretion of norepinephrine (h2= 66.565.0%, p = 3.2E-16) and dopamine (h2= 56.565.6%, p = 1.8E-13), and eGFR displayed genetic co-determination (covariance) with norepinephrine (rG=20.55760.088, p = 1.11E- 08) as well as dopamine (rG=20.22360.101, p = 2.3E-02). Since dopamine b-hydroxylase (DBH) catalyzes conversion of dopamine to norepinephrine, we studied functional variation at DBH ; DBH promoter haplotypes predicted transcriptional activity (p, 0.001), plasma DBH (p, 0.0001) and norepinephrine (p = 0.0297) secretion ; transcriptional activity was inversely (p, 0.0001) associated with basal eGFR. Meta- analysis validated DBH haplotype effects on eGFR across 3 samples. In NIDDK-AASK, we established a role for DBH promoter variation in long-term renal decline rate (GFR slope, p = 0.003). Conclusions: The heritable GFR trait shares genetic determination with catecholamines, suggesting new pathophysiologic, diagnostic and therapeutic approaches towards disorders of GFR as well as CKD. Adrenergic activity may play a role in progressive renal decline, and genetic variation at DBH may assist in profiling subjects for rational preventive treatment.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Glomerular filtration rate ; GFR ; dopamine beta-hydroxylase ; DBH ; chronic kidney disease ; CKD ; norepinephrine ; twin pair ; heritability ; genetic covariance |
Subjects: | NATURAL SCIENCES > Biology |
Divisions: | Division of Molecular Medicine |
Depositing User: | Maja Mustapić |
Date Deposited: | 09 Apr 2021 10:30 |
URI: | http://fulir.irb.hr/id/eprint/6379 |
DOI: | 10.1371/journal.pone.0082956 |
Actions (login required)
View Item |